Liplor A 10 Capsule contains a combination of Rosuvastatin 10 mg and Aspirin 75 mg, formulated to manage cardiovascular risk factors effectively. Rosuvastatin is a potent statin that works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol synthesis, thereby reducing low-density lipoprotein cholesterol (LDL-C) and triglycerides while modestly increasing high-density lipoprotein cholesterol (HDL-C). Aspirin, an antiplatelet agent, irreversibly inhibits cyclooxygenase-1 (COX-1), leading to decreased thromboxane A2 production and subsequent inhibition of platelet aggregation. This dual-action capsule is indicated for the prevention of atherosclerotic cardiovascular disease in patients at high risk, including those with a history of myocardial infarction, stroke, or established coronary artery disease. The combination helps in lowering lipid levels and reducing the risk of thrombotic events such as heart attacks and strokes. Liplor A 10 should be administered under medical supervision, with dosage adjustments based on individual patient profiles and response to therapy. Caution is advised in patients with hepatic or renal impairment, bleeding disorders, or those on concomitant anticoagulant therapy. Regular monitoring of lipid profiles, liver function tests, and signs of bleeding is recommended to ensure safety and efficacy during treatment.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.